See more : Daihatsu Diesel Mfg. Co., Ltd. (6023.T) Income Statement Analysis – Financial Results
Complete financial analysis of Hero Technologies Inc. (HENC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hero Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Ovoca Bio plc (OVXA.IR) Income Statement Analysis – Financial Results
- The Trade Desk, Inc. (TTD) Income Statement Analysis – Financial Results
- KEIWA Incorporated (4251.T) Income Statement Analysis – Financial Results
- China Ludao Technology Company Limited (2023.HK) Income Statement Analysis – Financial Results
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) Income Statement Analysis – Financial Results
Hero Technologies Inc. (HENC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://herotechnologiesinc.com
About Hero Technologies Inc.
Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.53K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
| Cost of Revenue | 1.98K | 72.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.98K | -71.16K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.64M | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | -4,666.30% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 505.00K | 1.17M | 5.78M | 74.37K | 0.00 | 0.00 | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 167.03K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 620.00 | 0.00 | 0.00 | 117.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 881.73K | 0.00 | 0.00 | 0.00 |
| SG&A | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 1.05M | 1.33M | 28.20K | 20.08K |
| Other Expenses | 0.00 | 2.05K | 0.00 | 0.00 | 0.00 | 0.00 | 229.40K | 0.00 | 0.00 | 0.00 | 3.40K | 6.81K | 625.73K | 0.00 | 0.00 | 47.42K | 0.00 | 0.00 |
| Operating Expenses | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
| Cost & Expenses | 507.60K | 1.24M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
| Interest Income | 183.00 | 46.96 | 58.90 | 53.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.28K | 0.00 | 0.00 |
| Interest Expense | 60.41K | 46.96K | 58.90K | 53.75K | 52.35K | 52.86K | 50.38K | 8.20K | 6.10K | 44.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.38K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.98K | 2.05K | 5.78M | 87.82K | 161.14K | 52.52K | 225.38K | -1.23M | 345.99 | 746.67K | -298.79K | -40.09K | 0.00 | 8.75M | -898.26K | 47.42K | 0.00 | 0.00 |
| EBITDA | -505.43K | -3.46M | -180.53K | -12.78M | 18.01K | -79.25K | 1.32K | -1.68M | 35.78K | 330.96K | -603.63K | -602.79K | -2.47M | -8.65M | -1.91M | -673.00K | -1.37M | -20.08K |
| EBITDA Ratio | 0.00% | -226,757.77% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -282.02% | -1,503.44% | 0.00% | 0.00% | 0.00% | -1,814.01% | 0.00% | 0.00% |
| Operating Income | -507.60K | -3.46M | -5.78M | -118.05K | -146.09K | -133.68K | -228.09K | -441.79K | 41.87K | -415.71K | -1.10M | -562.70K | -2.47M | -2.14M | -1.01M | -1.47M | -28.20K | -20.08K |
| Operating Income Ratio | 0.00% | -226,892.07% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -221.75% | -1,403.44% | 0.00% | 0.00% | 0.00% | -2,495.52% | 0.00% | 0.00% |
| Total Other Income/Expenses | -60.23K | -2.27M | -180.53K | -12.75M | 111.76K | 1.57K | 175.01K | -1.24M | 0.00 | 702.02K | 0.00 | 0.00 | 0.00 | -8.75M | 1.00 | 564.12K | -1.43M | 0.00 |
| Income Before Tax | -567.83K | -3.51M | -5.96M | -12.87M | -34.34K | -132.11K | -53.08K | -1.68M | 35.78K | 286.31K | -603.63K | -522.60K | -2.47M | -10.89M | -282.52K | -1.51M | -28.20K | -20.08K |
| Income Before Tax Ratio | 0.00% | -230,357.31% | -3,024,328.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -2.26M | 58.90K | -87.81 | -161.14K | -52.52K | 37.68K | 37.92K | -288.06K | 828.58K | -98.49K | 522.60K | 0.00 | -2.24M | -1.09M | 1.51M | 28.20K | 20.08K |
| Net Income | -541.58K | -1.25M | -6.02M | -12.87M | -34.34K | -132.11K | -90.76K | -1.72M | 323.84K | -542.27K | -603.63K | -522.60K | -2.47M | -8.65M | 808.32K | -1.51M | -28.20K | -20.08K |
| Net Income Ratio | 0.00% | -81,849.38% | -3,054,224.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 447.96M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
| Weighted Avg Shares Out (Dil) | 447.59M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
From Hero to Zero: 3 Cannabis Stocks to Avoid Like the Plague
The US is seeing a surge in cannabis legalization, with 39 states allowing medical use and 21 states permitting recreational use. Despite this, the cannabis industry has been grappling with economic and industry challenges, such as oversupply and inflation, which...
Google: The Power Of AI - Transforming Advertising Revenue Growth From Zero To Hero
Despite zero growth on Google's core advertising segment, the introduction of advanced AI capabilities like PaLM 2 has the potential to revolutionize the search experience and attract more advertisers. While Google's cloud segment holds growth potential, it may not have...
Data Center REIT ETF & Stocks: Unsung Hero of AI Boom
While the AI boom has been benefiting the tech stocks, data center REITs are also the beneficiaries.
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich
These biotech stocks are swinging for the fences. They may hit homers, they may strike out.
Hero or Zero? 7 High-Risk EV Stocks to Make You Rich
Succeeding in the increasingly crowded electric-vehicle market isn't a walk in the park for any company. As a result, I'm convinced some EV stocks will be winners and some will be losers.
Hero or Zero? 7 High-Risk Stocks to Make You Rich
As the saying goes, “nothing ventured, nothing gained.” That's the trade-off with high-risk stocks.
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich
High-risk penny stocks have long tempted investors with the potential for significant returns. However, it is crucial to acknowledge the inherent risks associated with these speculative investments.
Hero or Zero? 3 High-Risk Cybersecurity Stocks to Make You Rich
In today's increasingly interconnected world, the significance of cybersecurity has never been greater. As the digital landscape expands, so do the threats posed by cybercriminals.
Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich
While the traditional approach to market success calls for patiently investing in reliable blue chips, those that want to see more immediate gains may consider small-cap stocks to buy. Here, the point is about accepting massive risk to hopefully realize...
Hero or Zero? 3 High-Risk Metaverse Stocks to Make You Rich
Metaverse stocks are nowhere near as popular as they were a few years ago. They're seen as high-risk now.
Source: https://incomestatements.info
Category: Stock Reports